 |
 |
Company Press Release SOURCE: Strategic Research Institute New Pre-Clinical and Clinical Findings in Alzheimer's and Other Neurodegenerative Diseases to Be Presented by Pharmaceutical Industry & Academia at July 26-27 Conference in Princeton, NJ NEW YORK, July 7, 1999 /PRNewswire/ -- Significant new findings in understanding and treating Alzheimer's and other neurodegenerative diseases will be featured on July 26-27, 1999 in Princeton, NJ at the 3rd International ``Neurodegeneration in Alzheimer's Disease, Parkinson's Disease & Acute Stroke'' conference. Keynote speaker Dr. Steven Younkin of the Mayo Clinic Jacksonville will discuss the Role of Elevated Amyloid Beta Protein in Typical Late Onset Alzheimer's Disease, Dr. Michael Wolfe of Harvard Medical School will present his new work on B-Amyloid Gamma Secretase & Presenilins: Molecular Pieces in the AD Puzzle, and Dr. Ronald McKay of NIH will discuss his exciting new discoveries on Brain Stem Cells in Drug Discovery and the Treatment of Neurodegenerative Disease. Late-breaking clinical results of AIT-082 in Alzheimer's patients, developed by NeoTherapeutics, among other clinical work, shall also be presented. The conference is organized into three major sections focusing on the 1) understanding of neurodegenerative mechanisms, 2) neuroprotection/therapeutics, and 3) new approaches/clinical. <SNIP> http://biz.yahoo.com/prnews/990707/ny_alzheim_2.html Copyright © 1999 PRNewswire.